SARTORIUS STEDIM BIOTECH (56S1.DE) Stock Cash Flow
Europe - Frankfurt Stock Exchange - FRA:56S1 - FR0013154002 - Common Stock
205.9 EUR
-1.8 (-0.87%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 336.30M | 219.20M | 401.10M | 1.13B | 646.70M | |||
| Depreciation Amortization | 314.80M | 301.70M | 237.60M | 181.70M | 141.60M | |||
| Change In Working Capital | -74.10M | 140.60M | 57.80M | -566.90M | -306.50M | |||
| Interest Paid | 158.60M | 176.90M | 116.70M | 10.30M | 8.30M | |||
| Taxes Paid | 150.20M | 133.50M | 135.80M | 221.20M | 166.60M | |||
| Other non cash items | 153.60M | 153.60M | 49.90M | -132.90M | 220.10M | |||
| OPERATING CASH FLOW | 730.60M | 815.10M | 746.40M | 612.30M | 701.90M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -356.10M | -339.80M | -473.60M | -430.60M | -324.00M | |||
| Other Investing Activity | N/A | -200.00K | -2.25B | -526.90M | -141.20M | |||
| INVESTING CASH FLOW | -359.10M | -340.00M | -2.72B | -957.50M | -465.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -327.30M | -861.90M | 2.32B | 392.40M | -5.50M | |||
| Stock Issued/Repurchased | -1.20M | 1.19B | 1.30M | -3.20M | N/A | |||
| Dividend Paid | N/A | -67.10M | -132.70M | -116.10M | -62.70M | |||
| Other Financing Activity | -159.50M | -177.80M | -205.30M | -52.40M | -9.50M | |||
| FINANCING CASH FLOW | -555.10M | 84.90M | 1.99B | 220.70M | -77.70M | |||
| Exchange Rate Effect | -200.00K | 2.30M | -300.00K | 8.00M | 4.80M | |||
| CHANGE IN CASH | -183.80M | 562.30M | 9.50M | -116.50M | 163.80M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 730.60M | 815.10M | 746.40M | 612.30M | 701.90M | |||
| Capital Expenditure | -356.10M | -339.80M | -473.60M | -430.60M | -324.00M | |||
| FREE CASH FLOW | 374.50M | 475.30M | 272.80M | 181.70M | 377.90M | |||
All data in EUR